Investment
Features
FeesSafety
Academy
More
Pluang+

Compare GSK plc (GSK) vs KraneShares CSI China Internet ETF (KWEB) Price & Performance

KraneShares CSI China Internet ETFTrade

Price performance (Past 24H)

Key statistics

GSK plc vs KraneShares CSI China Internet ETF — how do they compare? GSK plc trades at $50.33 (market cap $102.60B), while KraneShares CSI China Internet ETF trades at $27.55. The key difference: GSK plc pays a 3.57% dividend while KraneShares CSI China Internet ETF pays none, and GSK plc is trading nearer its 52-week high, KraneShares CSI China Internet ETF nearer its low. Which is the better fit depends on your goals.

GSKKWEB
Market Cap
$102.60B
Sector
HealthSector/Thematic
52-Week High
$61.18$42.94
52-Week Low
$38.22$23.63
Enterprise Value
$123.04B
Dividend Yield
3.57%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

GSK plc

GSK trades at $50.27, down 3.62% today, with a bearish technical signal but strong fundamentals including a P/E of 16.02 and net income margin of 14.52%. Recent quarters show earnings beats, and the company announced a $2.52 billion cost-saving plan to boost its drug pipeline. Cash flow from operations remains robust at $7.74 billion for 2025.

The outlook is mixed: analyst consensus leans hold (55.18%) amid valuation concerns, but revenue growth and pipeline investments support long-term potential. Key risks include competitive pressures and regulatory uncertainty, as highlighted by recent news on vaccine policies. The stock offers a dividend yield with payments scheduled through 2026.

KraneShares CSI China Internet ETF

KWEB trades at $27.54, down 5.43% over 24 hours amid pressure on Chinese equities, with technical indicators showing a bullish moving average signal but neutral oscillators. Recent news highlights institutional buying and China's export strength, though regulatory and economic risks persist. The ETF focuses on Chinese internet and AI companies, with current sentiment mixed due to geopolitical and market volatility.

The outlook for KWEB hinges on China's economic recovery and AI sector growth, offering exposure to undervalued tech giants. Key risks include U.S.-China tensions and domestic regulatory shifts, while institutional accumulation suggests long-term confidence. Investors should weigh high growth potential against elevated geopolitical and market risks.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About GSK plc

In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.

Read more on GSK

About KraneShares CSI China Internet ETF

KWEB tracks the CSI Overseas China Internet Index, providing exposure to Chinese software and services companies listed in the US and Hong Kong, including giants like Tencent, Alibaba, and Meituan.

Read more on KWEB